Featured Posts
Blog
Free the Economy podcast: Drug costs and benefits with Sally Pipes
In this week’s episode we cover reforms to the Endangered Species Act, attacks on US tech firms, nuclear power innovation,…
National Review
Telehealth Is Less Promising Than It First Seemed
A key issue facing Congress in its postelection, “lame duck” session is whether to extend regulatory flexibilities expiring at year end that make telehealth services more…
City Journal
The FTC Jettisons Economics—and Law
The Federal Trade Commission is stepping up its pursuit of its new favorite bogeyman: Pharmacy Benefit Managers. Two months ago, the FTC issued an …
Search Posts
Citation
Our Phoniest Drug War
Op-Eds
Biotech Food Labeling is Regulatory Overkill: Henry Miller Op-Ed in LA Times
Published in the Los Angeles Times Published in the Los Angeles Times October 27, 2000 Headline: Biotech Food Labeling…
Op-Eds
Cracking Up Over Taco Shells; Why is the EPA Shelling Biotech Food? Henry Miller in Washington Times
Distributed nationally by Copley News Service Published in the Washington Times October 12, 2000 Kraft Foods has…
Op-Eds
A Much Higher Standard for Gene-Spliced Foods: Miller Op-Ed in SD Union-Tribune
Published in the San Diego Union-Tribune Published in the San Diego Union-Tribune October 5, 2000 Headline: A Much Higher…
Op-Eds
Effects of GM Confused with Those of Farming Practices: Conko Letter to Financial Times
Published in The Financial Times Published in The Financial Times September 6, 2000, Wednesday London Edition 1 …
Products
Throwing Precaution to the Wind: The Perils of the Precautionary Principle
From the August/September issue of CEI UpDate Mom always said, “Better safe than sorry.” Dad, on the other hand, believed…